| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.27336 |
| P932 | PMC publication ID | 5840026 |
| P698 | PubMed publication ID | 29460982 |
| P4011 | Semantic Scholar paper ID | 0b6b61e6537b633dc5a439b3562c62fc45dce8dc |
| P50 | author | Joseph Jankovic | Q6284337 |
| David Shprecher | Q63931385 | ||
| Benzi M Kluger | Q64856652 | ||
| Connie Fernández-Cid Marras | Q64857647 | ||
| Harvey Checkoway | Q64857717 | ||
| Yvette Bordelon | Q66724749 | ||
| Stephen G. Reich | Q67209057 | ||
| Hee Kyung Park | Q67211523 | ||
| Sindana Ilango | Q67211525 | ||
| Christina M Charriez | Q67211526 | ||
| David Riley | Q67211527 | ||
| Deborah Hall | Q67211530 | ||
| Richard Dubinsky | Q67211537 | ||
| Irene Litvan | Q38589459 | ||
| David G. Standaert | Q38801970 | ||
| P2093 | author name string | ENGENE-PSP Study | |
| P2860 | cites work | Reproductive factors and clinical features of Parkinson's disease | Q50249627 |
| Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia. | Q50802184 | ||
| Validation of a telephone questionnaire for Parkinson's disease. | Q50881050 | ||
| Risk of Parkinson disease in women: effect of reproductive characteristics. | Q51940269 | ||
| Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: a preliminary study | Q57549427 | ||
| Utility of TICS-M for the assessment of cognitive function in older adults | Q73210438 | ||
| A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging | Q73434963 | ||
| Age at menopause predicts age at onset of Parkinson's disease | Q79212192 | ||
| “Mini-mental state” | Q25938989 | ||
| Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations | Q28282629 | ||
| Postmenopausal estrogen use affects risk for Parkinson disease | Q30433773 | ||
| The effect of estrogen replacement on early Parkinson's disease | Q33607692 | ||
| Gender and incidence of dementia in the Framingham Heart Study from mid-adult life | Q33882491 | ||
| The FAB: a Frontal Assessment Battery at bedside. | Q33927821 | ||
| Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity | Q34201593 | ||
| Formulations of hormone therapy and risk of Parkinson's disease | Q34437648 | ||
| Increased risk of parkinsonism in women who underwent oophorectomy before menopause. | Q34673129 | ||
| Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop | Q34733901 | ||
| Update on epidemiological aspects of progressive supranuclear palsy | Q35540189 | ||
| A novel approach to data collection in a case-control study of cancer and occupational exposures | Q36832824 | ||
| Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study | Q36885365 | ||
| Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism | Q37001365 | ||
| Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation | Q37091609 | ||
| Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease | Q37362137 | ||
| The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project | Q37493067 | ||
| The neuroprotective actions of oestradiol and oestrogen receptors | Q38271320 | ||
| Estrogen actions in the nervous system: Complexity and clinical implications | Q38537500 | ||
| Tau and neurodegenerative disease: the story so far. | Q38658752 | ||
| Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system | Q42361824 | ||
| Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women | Q44274296 | ||
| Caffeine, postmenopausal estrogen, and risk of Parkinson's disease | Q44357392 | ||
| Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study | Q44429891 | ||
| Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study | Q44948891 | ||
| Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. | Q45933973 | ||
| Lifetime exposure to estrogens and Parkinson's disease in California teachers. | Q46008757 | ||
| Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease | Q47779309 | ||
| A clinical rating scale for progressive supranuclear palsy | Q48219228 | ||
| Cochrane corner: long-term hormone therapy for perimenopausal and postmenopausal women. | Q48355538 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | progressive supranuclear palsy | Q945930 |
| P577 | publication date | 2018-02-20 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study |
Search more.